Minimally invasive disc injection reduces pain and improves function in chronic back pain, feasibility study finds

VIVEX Biologics, Inc. sponsored research reports positive outcomes for patients with chronic lumbar discogenic pain treated using a single intradiscal injection of VIA Disc NP, an allogeneic nucleus pulposus product derived from cadaveric disc tissue.

Read More

Source:  Medical Xpress